The State Council's institutional reform plan was announced. According to this plan, the National Health Planning Commission, the Food and Drug Administration and the Medical Reform Office, which are closely related to the pharmaceutical industry, will be abolished, and the National Health and Wellness Committee, the State Administration of Market Supervision and the National Medical Insurance Bureau will be established. Taking drug supervision as an example, the drug regulatory agencies at the national level have undergone eight changes.
1. What are the key tasks of medical reform?
1. Further promote Sanming's medical reform experience and accelerate the linkage reform of medical care, medical insurance and medicine;
2. Promote the balanced distribution of high-quality medical resources and improve the grading diagnosis and treatment system;
3. Insist on prevention and strengthen the construction of public health system;
4. Fourth, coordinate and promote relevant key reforms to form a joint effort;
2. What progress has been made in medical reform?
1, start the pilot of hypertension, hyperglycemia and hyperlipidemia, and improve the integrated management ability of medical prevention of chronic diseases at the grassroots level;
2. Encourage the innovation of drugs and medical devices, and promote rational drug use and inspection;
3. Strengthen the management and operation of medical associations, promote the grid layout, promote the construction of urban medical groups and county medical institutions, and develop telemedicine and Internet hospitals;
4, to carry out public health prevention and control capacity building, improve the public health emergency material security system, and promote the normalization of epidemic prevention and control.
Legal basis:
Interim Measures for the Fixed-point Management of Medical Security in Medical Institutions
Thirteenth designated medical institutions have the right to obtain medical insurance settlement fees after providing medical services for insured persons according to law, supervise the performance of agencies, and put forward opinions and suggestions on improving medical insurance policies.
Article 14 Designated medical institutions shall strictly implement the medical insurance agreement, make reasonable diagnosis and treatment, charge reasonable fees, strictly implement the list of medical insurance drugs, medical consumables and medical services, give priority to the use of drugs outside the medical insurance list, control the proportion of patients paying their own expenses, and improve the efficiency of the use of medical security funds. Designated medical institutions shall not provide medical insurance settlement for non-designated medical institutions. The unpaid expenses of the agency, the quality deposit deducted by the designated medical institutions according to the medical insurance agreement and the liquidated damages paid by the designated medical institutions shall not be treated as arrears of medical insurance.